Pedro Corpuz

Director of Biomarker Operations @Alumis

San Francisco, CA, US
MOBILE NUMBERS
+16•••••••06

Signup · Get unlimited contacts

WORK HISTORY

Apr 2022 — Present

Director of Biomarker Operations @Alumis

View department →

US

Head of Biomarker Operations/Precision Medicine Biospecimen Operations-People manager and created a team to support the entire lifecycle of biospecimen management for clinical studies for PK, PD, Biomarkers, LDT/CDx, Drug Metabolism, NGS, Precision Medicine, and novel personalized medicine technologies-created SOPs, processes and lead the Biomarker Sub-Teams for all indications-Piloted several biomarker collection strategies for multi-omics and implemented in our clinical trials-Collaborated intensively with biomarker scientists, medical monitors, data management, bioinformaticians and precision medicine colleagues to help create a biomarker operations strategy and it\'s implementation in the autoimmune/immunology space-Connector of people and ideas within the company and my network to foster innovations and dialog with industry challenges and lessons learned.

EDUCATION

N/A

University of Puget Sound

BS

SKILLS

Product InnovationU.s. Food and Drug Administration (Fda)Microsoft ExcelMicrosoft PowerpointImmunologyGlpData ManagementProduct DevelopmentResearchBiotechnologyOperational ExcellencePharmaceutical IndustrySopCRO ManagementGood Laboratory Practice (Glp)ValidationDesign ThinkingMobile ApplicationsLife SciencesStandard Operating Procedure (Sop)LimsGood Clinical Practice (Gcp)Microsoft WordClinical ResearchMolecular BiologyDrug DevelopmentBiopharmaceuticalsOncologyClinical TrialsProtocolLifesciencesLaboratory Information Management System (Lims)GmpMicrosoft OfficeClinical DevelopmentWhat-If Analysis

ABOUT PEDRO CORPUZ

Alumis empowers innovative biomarker strategies under my leadership, where I oversee the full lifecycle of biospecimen management across clinical trials. With over three years at Alumis, I’ve spearheaded the creation of SOPs, directed biomarker sub-teams, and implemented multi-omics collection strategies to support autoimmune and immunology pipelines. Collaborative efforts with biomarker scientists, medical monitors, and bioinformaticians have driven operational success in translational and precision medicine initiatives. Over a decade of expertise in translational medicine and biospecimen operations underpins my commitment to advancing precision medicine. Past roles at Arcus Biosciences and Gilead Sciences honed my skills in clinical trial biosample management, biomarker planning, and vendor collaboration. My leadership fosters a culture of innovation and operational excellence, ensuring impactful contributions to clinical development and personalized healthcare solutions.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.